Consonance Capital Partners, a NYC-based healthcare private equity firm, closed Consonance Private Equity II, L.P., at $856m.
Fund II received support from existing investors, as well as from a select number of new limited partners. The diverse investor mix is comprised of leading insurers, endowments, foundations, family offices, asset managers, funds of funds, pension plans, and strategic healthcare providers in the United States and Europe.
Consistent with its predecessor fund, Fund II will focus on investments in U.S. healthcare companies in the lower and middle markets.
Led by Managing Partners and Co-Founders Mitchell Blutt, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, Consonance Capital Partners invests in private companies in the lower and middle markets of the U.S. healthcare industry with an emphasis on businesses driving efficiency, cost containment, and high quality care to patients. The firm participates in growth equity, leveraged buyout, carve-out, recapitalization, and special situation transactions.
FinSMEs
30/04/2020